TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

Market News Page 1 of 178 • 4,427 articles
ATYR CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds aTyr Investors to Contact the Firm Before December 8th Regarding Their Rights
GlobeNewswire Inc. • Bragar Eagel & Squire, P.C.
ATYR CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds aTyr Investors to Contact the Firm Before December 8th Regarding Their Rights

12/06/2025 08:53 AM • A class action lawsuit has been filed against aTyr Pharma alleging false and misleading statements about the efficacy of their drug Efzofitimod, with investors having until December 8, 2025 to apply as lead plaintiff.

ATYR - The lawsuit alleges the company made materially false statements about their drug's capabilities, potentially misleading investors and causing artificial inflation of stock prices
#class action #lawsuit #securities #pharmaceutical #investor rights
Read More
CBD Nutraceuticals Market Projected to Reach USD 39.06 Billion by 2032 at 16.38% CAGR – SNS Insider
GlobeNewswire Inc. • Sns Insider
CBD Nutraceuticals Market Projected to Reach USD 39.06 Billion by 2032 at 16.38% CAGR – SNS Insider

12/06/2025 08:45 AM • The CBD nutraceuticals market is projected to grow from $9.75 billion in 2023 to $39.06 billion by 2032, driven by increasing consumer interest in natural wellness solutions and gradual product legalization.

CVSI - Acquired Elevated Softgels LLC, enhancing global presence in CBD nutraceuticals industry
#CBD #nutraceuticals #wellness #natural health #market growth
Read More
K-Shaped Growth And Policy Volatility, JP Morgan's 2026 Outlook
Benzinga • Stjepan Kalinic
K-Shaped Growth And Policy Volatility, JP Morgan's 2026 Outlook

12/06/2025 08:43 AM • JP Morgan predicts a K-shaped economic growth in 2026, with uneven market performance driven by policy factors like tariffs, immigration, and AI investments. The bank expects continued U.S. economic expansion with moderate inflation and cautious interest rate adjustments.

IEMG - JP Morgan suggests potential for international market rotation, with emerging markets offering attractive investment opportunities
#K-shaped growth #economic outlook #AI investment #tariffs #interest rates
Read More
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages StubHub Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – STUB
GlobeNewswire Inc. • Rosen Law Firm
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages StubHub Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – STUB

12/06/2025 08:34 AM • Rosen Law Firm alerts StubHub Holdings investors about a potential securities class action lawsuit alleging misleading financial statements related to vendor payment timing and free cash flow impacts, with a lead plaintiff deadline of January 23, 2026.

STUB - The lawsuit alleges the company's registration statement was materially false and misleading, suggesting potential financial misrepresentation and potential investor damages
#securities class action #IPO #investor rights #financial disclosure
Read More
Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
GlobeNewswire Inc. • Disc Medicine
Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting

12/06/2025 08:00 AM • Disc Medicine reported promising results from its Phase 2 trial of DISC-0974 for treating anemia in myelofibrosis patients, demonstrating substantial hematologic responses across different patient subgroups and transfusion statuses.

GOOGL - Strong cloud revenue growth (34% YoY), profitable cloud business, top-performing AI model, trading at attractive valuation, and significant stock price recovery
IRON - Presented strong clinical trial results showing meaningful anemia responses, reduced transfusion burden, and potential for addressing an unmet medical need in myelofibrosis treatment
#myelofibrosis #anemia #clinical trial #hematology #DISC-0974
Read More
Canada’s Tenth Costco Business Centre is now open in East Gwillimbury
GlobeNewswire Inc. • Marc-André Bally
Canada’s Tenth Costco Business Centre is now open in East Gwillimbury

12/06/2025 08:00 AM • Costco Wholesale opened its tenth Canadian Business Centre in East Gwillimbury, Ontario, creating 240 local jobs and offering over 3,000 unique business-focused products. The 137,000 square-foot facility provides specialized items for restaurants, stores, and offices, with next-day delivery and extended business hours.

COST - Expanding business operations, creating local jobs, introducing new business-focused service model, demonstrating growth and strategic market expansion
#business centre #retail #job creation #commercial products #warehouse
Read More
Bicara Therapeutics’ Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026
GlobeNewswire Inc. • Bicara Therapeutics
Bicara Therapeutics’ Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026

12/06/2025 08:00 AM • Bicara Therapeutics reported promising Phase 1b data for ficerafusp alfa, a bifunctional antibody, in treating HPV-negative head and neck squamous cell carcinoma. The 750mg weekly dose showed a 57% confirmed overall response rate and was well-tolerated when combined with pembrolizumab.

GLW - Partnered with QuantumScape to develop ceramic battery separators, indicating potential for future collaboration
BCAX - Demonstrated promising clinical trial results with a 57% overall response rate, consistent safety profile, and potential for meaningful patient outcomes in head and neck cancer treatment
#ficerafusp alfa #head and neck cancer #immunotherapy #clinical trials #TGF-β inhibition
Read More
Carbon Credit Trading Platform Market Size to Exceed USD 1513.44 Million by 2033, at 25% CAGR | SNS Insider
GlobeNewswire Inc. • Sns Insider
Carbon Credit Trading Platform Market Size to Exceed USD 1513.44 Million by 2033, at 25% CAGR | SNS Insider

12/06/2025 08:00 AM • The carbon credit trading platform market is projected to grow from USD 253.91 million in 2025 to USD 1513.44 million by 2033, driven by stricter emission regulations, corporate net-zero goals, and increasing demand for digital carbon credit transactions.

VWAGY - Actively partnering with QuantumScape, planning field tests of electric motorcycle with new battery technology
NDAQ - Projected significant growth in carbon offset demand, with potential market worth up to USD 50 billion by 2030
#carbon credits #carbon trading #sustainability #emissions reduction #net-zero
Read More
Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting
GlobeNewswire Inc. • Beam Therapeutics
Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting

12/06/2025 08:00 AM • Beam Therapeutics presented promising clinical trial results for risto-cel, a base editing cell therapy for sickle cell disease, showing high hemoglobin F induction, reduced hemoglobin S, and durable anemia resolution in 31 patients.

BEAM - Reported strong clinical trial results with high editing efficiency, rapid patient engraftment, and no severe vaso-occlusive crises, indicating promising progress in developing a potential transformative therapy for sickle cell disease
#sickle cell disease #base editing #genetic medicine #clinical trial #hemoglobin
Read More
1 Risky ETF You Want to Avoid Buying in December
The Motley Fool • Stefon Walters
1 Risky ETF You Want to Avoid Buying in December

12/06/2025 07:33 AM • The Vanguard Information Technology ETF (VGT) has performed well in 2023, but carries high risk due to extreme concentration in three major tech stocks: Nvidia, Apple, and Microsoft, which collectively represent over 45% of the ETF's holdings.

VGT - High concentration risk with top 3 stocks representing over 45% of ETF, making it vulnerable to performance fluctuations
#ETF #technology #market concentration #investment risk
Read More
Stormwater Detention System Market Size to Hit USD 876.02 Million by 2033 | Research by SNS Insider
GlobeNewswire Inc. • Sns Insider
Stormwater Detention System Market Size to Hit USD 876.02 Million by 2033 | Research by SNS Insider

12/06/2025 07:00 AM • The global stormwater detention system market is projected to grow from $592.92 million in 2025 to $876.02 million by 2033, driven by urbanization, flood prevention needs, and sustainable drainage solutions.

FFWM - Being acquired by FirstSun Capital Bancorp through share exchange, potential investigation implies possible examination of transaction fairness
WMS - Introducing innovative eco-pure biofilter solutions for urban stormwater management, demonstrating technological advancement and market adaptability
#stormwater management #urban infrastructure #flood prevention #sustainable drainage
Read More
Putin Pledges Uninterrupted Oil Flows To India, Questions US Policy As Both Nations Set $100 Billion Trade Goal
Benzinga • Mohd Haider
Putin Pledges Uninterrupted Oil Flows To India, Questions US Policy As Both Nations Set $100 Billion Trade Goal

12/06/2025 03:41 AM • Russian President Vladimir Putin met with Indian Prime Minister Narendra Modi, pledging continued energy shipments and targeting $100 billion in annual trade by 2030, while challenging US sanctions policy and defending India's oil purchases.

BHFAP - Being sold to Aquarian Capital LLC for $70.00 per share, potential investigation indicates possible scrutiny of sale conditions
PIN - Strengthening strategic partnership with Russia, securing energy resources, and resisting external economic pressures
#Russia #India #oil trade #energy partnership #sanctions #diplomatic relations
Read More
Tim Cook's AI Reset Will Pay Off, Gene Munster Says— Predicts Apple's Top Mag 7 Performance
Benzinga • Ananya Gairola
Tim Cook's AI Reset Will Pay Off, Gene Munster Says— Predicts Apple's Top Mag 7 Performance

12/06/2025 03:30 AM • Gene Munster believes Apple's recent leadership changes are a strategic reset to strengthen its AI position, predicting the company will lead the Magnificent 7 stocks through spring despite executive departures.

GDEN - Selling operating assets and casino real estate, with complex transaction involving share exchange and cash payment, potential legal review suggested
AAPL - Munster views the executive shake-up as a deliberate refresh to accelerate AI ambitions, expects strong iPhone sales, and predicts Apple will be the best-performing Magnificent 7 stock in the near term
#AI #leadership #Apple #Magnificent 7 #executive changes
Read More
Analyst Says Netflix-Warner Bros Merger Is About More Than Movies— It's An AI Play
Benzinga • Mohd Haider
Analyst Says Netflix-Warner Bros Merger Is About More Than Movies— It's An AI Play

12/06/2025 01:34 AM • Netflix's $82.7 billion acquisition of Warner Bros. Discovery is strategically positioned as an AI and technology play, with a focus on building a competitive video content corpus for AI training and challenging Google's technological dominance.

BHFAO - Being sold to Aquarian Capital LLC for $70.00 per share, potential investigation indicates possible scrutiny of sale conditions
NFLX - Seeking strategic positioning in AI and content generation by acquiring Warner Bros. Discovery to compete with Google's technological capabilities
#AI #merger #video content #technology #chips
Read More
James Hardie Industries plc (JHX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law
GlobeNewswire Inc. • Robbins Geller Rudman & Dowd Llp
James Hardie Industries plc (JHX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law

12/06/2025 12:45 AM • James Hardie Industries faces a class action lawsuit alleging securities fraud related to misleading statements about North America Fiber Cement sales and inventory destocking, with stock price dropping over 34% after disclosure.

BHFAM - Being sold to Aquarian Capital LLC for $70.00 per share, potential investigation indicates possible scrutiny of sale conditions
JHX - Lawsuit alleges fraudulent misrepresentation of sales performance, deliberately misleading investors about customer inventory levels, resulting in significant stock price decline of over 34%
#securities fraud #class action lawsuit #inventory destocking #stock price #investor losses
Read More
This Under-$10 Stock Could Be About to Go Parabolic
The Motley Fool • Brett Schafer
This Under-$10 Stock Could Be About to Go Parabolic

12/06/2025 12:34 AM • The Real Brokerage, a cloud-based real estate brokerage, is experiencing rapid growth by offering innovative software and services for real estate agents, with 53% year-over-year revenue growth and potential for significant market expansion.

BHFAN - Being sold to Aquarian Capital LLC for $70.00 per share, potential investigation indicates possible scrutiny of sale conditions
REAX - The company is showing strong revenue growth (53% YoY), expanding its agent network to over 30,000, and adding new services that could help capture a larger share of the real estate market
#real estate #cloud brokerage #technology #market share #revenue growth
Read More
Netflix-Warner Bros $82.7 Billion Mega-Merger Sparks Fierce Hollywood, Lawmakers Backlash— Elizabeth Warren Calls It An 'Anti-Monopoly Nightmare'
Benzinga • Ananya Gairola
Netflix-Warner Bros $82.7 Billion Mega-Merger Sparks Fierce Hollywood, Lawmakers Backlash— Elizabeth Warren Calls It An 'Anti-Monopoly Nightmare'

12/05/2025 11:38 PM • Netflix's proposed $82.7 billion acquisition of Warner Bros. Discovery has triggered significant criticism from lawmakers and Hollywood unions, with concerns about market consolidation, potential job losses, and reduced consumer choices.

BHFAL - Being sold to Aquarian Capital LLC for $70.00 per share, potential investigation indicates possible scrutiny of sale conditions
NFLX - Facing strong opposition from politicians and industry professionals who argue the merger could create a monopolistic streaming platform, limit consumer choices, and potentially harm job markets
#merger #antitrust #streaming #media consolidation #Elizabeth Warren
Read More
התראת מועד חשוב לתביעה נגד MLTX: רוזן, עורכי דין מקצועיים למשפטים, מעודדים את משקיעי MoonLake Immunotherapeutics להשיג ייעוץ משפטי לפני המועד החשוב של 15 בדצמבר בתביעה ייצוגית בניירות ערך – MLTX
GlobeNewswire Inc. • Rosen Law Firm
התראת מועד חשוב לתביעה נגד MLTX: רוזן, עורכי דין מקצועיים למשפטים, מעודדים את משקיעי MoonLake Immunotherapeutics להשיג ייעוץ משפטי לפני המועד החשוב של 15 בדצמבר בתביעה ייצוגית בניירות ערך – MLTX

12/05/2025 09:39 PM • Rosen Law Firm alerts MoonLake Immunotherapeutics investors about a December 15, 2025 deadline for a securities class action lawsuit, alleging false or misleading statements about the company's nanobody and monoclonal antibody technologies.

MLTX - The lawsuit alleges the company made false or misleading statements about its technological capabilities, specifically regarding the comparative advantages of its nanobody structure (SLK) versus traditional monoclonal antibodies, suggesting potential misrepresentation of clinical potential
#securities lawsuit #class action #investor rights #nanobody #monoclonal antibodies
Read More
מועד אחרון לתביעה נגד ATYR: רוזן, משרד עורכי דין מוערך בעולם, מעודדים את משקיעי ATyr Pharma, Inc עם הפסדים של מעל מאה אלף דולר, להשיג ייעוץ לפני המועד החשוב של 8 בדצמבר בתביעה ייצוגית בניירות ערך - ATYR
GlobeNewswire Inc. • Rosen Law Firm
מועד אחרון לתביעה נגד ATYR: רוזן, משרד עורכי דין מוערך בעולם, מעודדים את משקיעי ATyr Pharma, Inc עם הפסדים של מעל מאה אלף דולר, להשיג ייעוץ לפני המועד החשוב של 8 בדצמבר בתביעה ייצוגית בניירות ערך - ATYR

12/05/2025 09:38 PM • Rosen Law Firm alerts ATyr Pharma investors about a securities class action lawsuit deadline on December 8, 2025, related to allegedly misleading statements about the effectiveness of the drug Efzofitimod.

BHF - Being sold to Aquarian Capital LLC for $70.00 per share, potential investigation indicates possible scrutiny of sale conditions
ATYR - The lawsuit alleges the company made false and misleading statements about their drug's effectiveness, potentially causing significant investor losses, indicating serious corporate governance and transparency issues
#securities lawsuit #class action #investor rights #pharmaceutical #drug effectiveness
Read More
Should You Buy Bitcoin While It's Under $100,000?
The Motley Fool • Dominic Basulto
Should You Buy Bitcoin While It's Under $100,000?

12/05/2025 08:36 PM • Bitcoin is experiencing a price decline but remains attractive compared to other cryptocurrencies. Despite being down 30% from its all-time high, historical patterns suggest potential future recovery and growth.

MSTR - Stock down 35% for the year with potential financial challenges and risk of selling Bitcoin holdings
#Bitcoin #cryptocurrency #crypto market #investment #volatility
Read More
ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20 Mutations at the ESMO Asia Congress 2025
GlobeNewswire Inc. • Oric Pharmaceuticals
ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20 Mutations at the ESMO Asia Congress 2025

12/05/2025 08:00 PM • ORIC Pharmaceuticals presented promising Phase 1b trial results for enozertinib, demonstrating strong systemic and CNS activity in NSCLC patients with EGFR exon 20 mutations, with high objective response rates and a competitive safety profile.

AKRO - Being acquired by Novo Nordisk with cash payment and contingent value right
ORIC - Presented strong preliminary clinical trial data showing high objective response rates (67% in 1L, 45% in 2L), 100% intracranial response in some patient groups, manageable safety profile, and potential best-in-class positioning for their drug enozertinib
#enozertinib #NSCLC #EGFR #clinical trial #oncology
Read More
Anika Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors ANIK
GlobeNewswire Inc. • Kirby Mcinerney Llp
Anika Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors ANIK

12/05/2025 08:00 PM • Law firm investigating potential securities fraud at Anika Therapeutics after clinical trial results showed missed endpoints, causing stock price to drop 27.42% on July 30, 2025.

CADEpA - Proposed sale to Huntington Bancshares with stock conversion ratio of 2.475 shares
ANIK - Stock price dropped significantly after clinical trial failed to meet pre-specified endpoints, with potential legal investigation suggesting potential misrepresentation of trial results
#securities fraud #clinical trial #Hyalofast #stock decline
Read More
JHX DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages James Hardie Industries plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – JHX
GlobeNewswire Inc. • Rosen Law Firm
JHX DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages James Hardie Industries plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – JHX

12/05/2025 07:57 PM • Rosen Law Firm is pursuing a securities class action against James Hardie Industries for allegedly misleading investors about the strength of its North America Fiber Cement segment between May 20 and August 18, 2025.

GES - Proposed sale to Authentic Brands Group and insiders at $16.75 per share
JHX - The lawsuit alleges the company falsely claimed demand was strong and stock levels were 'normal' despite knowing distributors were destocking inventory, which suggests intentional misrepresentation of financial performance
#securities lawsuit #class action #investor rights #misleading statements
Read More
Why Rubrik Stock Surged Today
The Motley Fool • Joe Tenebruso
Why Rubrik Stock Surged Today

12/05/2025 06:36 PM • Cybersecurity company Rubrik reported strong Q3 performance with 48% revenue growth and 34% increase in subscription ARR, driven by AI-powered solutions and improved profitability.

CADE - Proposed sale to Huntington Bancshares with stock conversion ratio of 2.475 shares
RBRK - Strong financial performance with 48% revenue growth, 34% ARR increase, improved gross margins from 76.2% to 80.5%, narrowed net loss, and positive adjusted earnings exceeding Wall Street expectations
#cybersecurity #AI #data protection #cloud #enterprise technology
Read More
Webus International Limited Issues Clarification on Previous Announcement Related to Expedia Group
GlobeNewswire Inc. • Annabelle Li
Webus International Limited Issues Clarification on Previous Announcement Related to Expedia Group

12/05/2025 06:00 PM • Webus International Limited issued a clarification regarding its previous press release about an Expedia partnership, stating that its engagement was limited to the Travel Agent Affiliate Program. Expedia has terminated Webus' TAAP access as of November 10, 2025.

WETO - Company had to publicly retract previous claims about partnership scope and lost access to Expedia's Travel Agent Affiliate Program
#partnership #termination #travel tech #TAAP #clarification
Read More